• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 老年住院患者的临床、生物学和放射学特征、4 周结局和预后因素。

Clinical, biological and radiological features, 4-week outcomes and prognostic factors in COVID-19 elderly inpatients.

机构信息

Sorbonne Université, Inserm, Pierre Louis Epidemiology and Public Health Institute (iPLESP), AP-HP, Pitié-Salpêtrière Hospital, Department of Infectious Diseases, 47-83, boulevard de l'hôpital, 75013 Paris, France.

Sorbonne Université, Inserm, Pierre Louis Epidemiology and Public Health Institute (iPLESP), AP-HP, Pitié-Salpêtrière Hospital, Department of Infectious Diseases, 47-83, boulevard de l'hôpital, 75013 Paris, France.

出版信息

Infect Dis Now. 2021 Jun;51(4):368-373. doi: 10.1016/j.idnow.2020.12.004. Epub 2021 Jan 18.

DOI:10.1016/j.idnow.2020.12.004
PMID:33495763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7816947/
Abstract

OBJECTIVE

To describe clinical, biological, radiological presentation and W4 status in COVID-19 elderly patients.

PATIENTS AND METHODS

All patients ≥ 70 years with confirmed SARS-CoV-2 infection and hospitalized in the Infectious Diseases department of the Pitié-Salpêtrière hospital, Paris, France, from March 1st to April 15th 2020 were included. The primary outcome was death four weeks after hospital admission. Data on demographics, clinical features, laboratory tests, CT-scan findings, therapeutic management and complications were collected.

RESULTS

All in all, 100 patients were analyzed, including 49 patients ≥ 80 years. Seventy percent had ≥2 comorbidities. Respiratory features were often severe as 48% needed oxygen support upon admission. Twenty-eight out of 43 patients (65%) with a CT-scan had mild to severe parenchymal impairment, and 38/43 (88%) had bilateral impairment. Thirty-two patients presented respiratory distress requiring oxygen support ≥ 6 liters/minute. Twenty-four deaths occurred, including 21 during hospitalization in our unit, 2 among the 8 patients transferred to ICU, and one at home after discharge from hospital, leading to a global mortality rate of 24% at W4. Age, acute renal failure and respiratory distress were associated with mortality at W4.

CONCLUSION

A substantial proportion of elderly COVID-19 patients with several comorbidities and severe clinical features survived, a finding that could provide arguments against transferring the most fragile patients to ICU.

摘要

目的

描述 COVID-19 老年患者的临床、生物学、影像学表现和 W4 状态。

患者和方法

纳入所有 2020 年 3 月 1 日至 4 月 15 日期间在法国巴黎皮提-萨尔佩特里埃医院传染病科住院的年龄≥70 岁且确诊 SARS-CoV-2 感染的患者。主要结局为住院四周后的死亡。收集了人口统计学、临床特征、实验室检查、CT 扫描结果、治疗管理和并发症的数据。

结果

共分析了 100 例患者,其中≥80 岁的患者 49 例。70%的患者合并≥2 种合并症。入院时呼吸症状常很严重,48%的患者需要氧疗支持。43 例中有 CT 扫描的患者中,28 例(65%)有轻至重度实质损害,38/43 例(88%)有双侧损害。32 例患者出现需要≥6 升/分钟氧疗支持的呼吸窘迫。共有 24 例死亡,包括在我们科室住院期间死亡的 21 例,转入 ICU 的 8 例中的 2 例,出院后在家死亡的 1 例,导致 W4 时的总死亡率为 24%。年龄、急性肾衰和呼吸窘迫与 W4 时的死亡率相关。

结论

相当一部分合并多种合并症和严重临床特征的老年 COVID-19 患者存活,这一发现可能为不将最脆弱的患者转入 ICU 提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/7816947/ae33b13119a9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/7816947/c78fa360d000/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/7816947/ae33b13119a9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/7816947/c78fa360d000/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/7816947/ae33b13119a9/gr2.jpg

相似文献

1
Clinical, biological and radiological features, 4-week outcomes and prognostic factors in COVID-19 elderly inpatients.COVID-19 老年住院患者的临床、生物学和放射学特征、4 周结局和预后因素。
Infect Dis Now. 2021 Jun;51(4):368-373. doi: 10.1016/j.idnow.2020.12.004. Epub 2021 Jan 18.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients.建立 ICU 转科或死亡的多变量预测模型:一项法国前瞻性队列研究COVID-19 住院患者。
PLoS One. 2020 Oct 19;15(10):e0240711. doi: 10.1371/journal.pone.0240711. eCollection 2020.
4
Patients' treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections.患者的治疗限制作为 COVID-19 患者死亡的预测因素:来自 SARS-CoV-2 感染热点地区住院患者的结果。
Respir Res. 2021 Jun 4;22(1):168. doi: 10.1186/s12931-021-01756-2.
5
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.新德里一家三级医疗中心SARI病房中新冠病毒患者的临床和流行病学特征
J Assoc Physicians India. 2020 Jul;68(7):19-26.
6
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
7
Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis.对类肉瘤病患者 SARS-CoV-2 感染的特征及结果分析。
Viruses. 2021 May 27;13(6):1000. doi: 10.3390/v13061000.
8
Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort.肝功能试验异常与 COVID-19 患者预后较差相关:法国队列研究结果。
Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101556. doi: 10.1016/j.clinre.2020.10.002. Epub 2020 Oct 19.
9
Multicenter Study of Temporal Changes and Prognostic Value of a CT Visual Severity Score in Hospitalized Patients With Coronavirus Disease (COVID-19).多中心研究:住院的新型冠状病毒肺炎(COVID-19)患者 CT 视觉严重程度评分的时间变化及其预后价值。
AJR Am J Roentgenol. 2021 Jul;217(1):83-92. doi: 10.2214/AJR.20.24044. Epub 2020 Sep 9.
10
Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19.开发和验证 COVID-19 住院患者 40 天死亡风险预测模型。
PLoS One. 2021 Jul 30;16(7):e0255228. doi: 10.1371/journal.pone.0255228. eCollection 2021.

引用本文的文献

1
The relationship between different severity of COVID-19 pneumonia and arterial stiffness based on artificial intelligence analysis.基于人工智能分析的新型冠状病毒肺炎不同严重程度与动脉僵硬度之间的关系
Front Med (Lausanne). 2025 Aug 29;12:1594570. doi: 10.3389/fmed.2025.1594570. eCollection 2025.
2
Prevalence, Pattern and Functional Outcome of Post COVID-19 Syndrome in Older Adults.老年人新冠后综合征的患病率、模式及功能转归
Cureus. 2021 Aug 15;13(8):e17189. doi: 10.7759/cureus.17189. eCollection 2021 Aug.

本文引用的文献

1
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.COVID-19 重症患者全身使用皮质类固醇与死亡率的关联:一项荟萃分析。
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
2
Clinical Characteristics and Outcomes of 821 Older Patients With SARS-Cov-2 Infection Admitted to Acute Care Geriatric Wards.821 例老年 SARS-CoV-2 感染患者入住急性护理老年病房的临床特征和结局。
J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):e4-e12. doi: 10.1093/gerona/glaa210.
3
Clinical and CT findings of COVID-19: differences among three age groups.
COVID-19 的临床和 CT 表现:三个年龄组之间的差异。
BMC Infect Dis. 2020 Jun 22;20(1):434. doi: 10.1186/s12879-020-05154-9.
4
Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital.羟氯喹在法国某大学附属医院轻至重度 COVID-19 患者中的临床应用
Clin Infect Dis. 2021 Dec 6;73(11):e4064-e4072. doi: 10.1093/cid/ciaa791.
5
Risk Factors for Mortality and Respiratory Support in Elderly Patients Hospitalized with COVID-19 in Korea.韩国 COVID-19 住院老年患者的死亡和呼吸支持危险因素。
J Korean Med Sci. 2020 Jun 15;35(23):e223. doi: 10.3346/jkms.2020.35.e223.
6
Should we deny ICU admission to the elderly? Ethical considerations in times of COVID-19.我们是否应该拒绝老年人进入重症监护病房?新冠疫情时期的伦理考量。
Crit Care. 2020 Jun 9;24(1):321. doi: 10.1186/s13054-020-03050-x.
7
Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications.新型冠状病毒肺炎多系统疾病老年患者的评估与治疗:临床及伦理意义
Acta Biomed. 2020 May 11;91(2):150-168. doi: 10.23750/abm.v91i2.9629.
8
Is the kidney a target of SARS-CoV-2?肾脏是否是 SARS-CoV-2 的靶器官?
Am J Physiol Renal Physiol. 2020 Jun 1;318(6):F1454-F1462. doi: 10.1152/ajprenal.00160.2020. Epub 2020 May 15.
9
Pulmonary embolism in patients with COVID-19 pneumonia.COVID-19 肺炎患者中的肺栓塞。
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01365-2020. Print 2020 Jul.
10
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的观察性研究。
N Engl J Med. 2020 Jun 18;382(25):2411-2418. doi: 10.1056/NEJMoa2012410. Epub 2020 May 7.